Investing.com - GlaxoSmithKline ADR reported on Wednesday first quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
GlaxoSmithKline ADR announced earnings per share of £0.23 on revenue of £7.42B. Analysts polled by Investing.com anticipated EPS of £0.5931 on revenue of £10.89B.
GlaxoSmithKline ADR shares are up 11% from the beginning of the year and are trading at £37.73 , down-from-52-week-high.They are outperforming the STOXX 600 which is up 10.31% from the start of the year.
GlaxoSmithKline ADR follows other major Healthcare sector earnings this month
GlaxoSmithKline ADR's report follows an earnings beat by J&J on April 20, who reported EPS of £2.59 on revenue of £22.32B, compared to forecasts EPS of £2.34 on revenue of £21.98B.
Abbott Labs had beat expectations on April 20 with first quarter EPS of £1.32 on revenue of £10.46B, compared to forecast for EPS of £1.27 on revenue of £10.69B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar